Tommaso Gori

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen et al. · The Lancet · 2017 · 590 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Davide Capodanno, Tommaso Gori, Holger Nef et al. · EuroIntervention · 2015 · 451 citations

Medicine, Cardiology, Surgery +17

Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial

Lucas V.A. Boersma, Hueseyin Ince, Stephan Kische et al. · Heart Rhythm · 2017 · 442 citations · Full text

Medicine, Cardiology, Surgery +14

Application of High-Sensitivity Troponin in Suspected Myocardial Infarction

Raphael Twerenbold, Francisco Ojeda, Nils A. Sörensen et al. · New England Journal of Medicine · 2019 · 341 citations · Full text

Medicine, Cardiology, Internal Medicine +16